These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36627449)

  • 1. Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody.
    VanAernum ZL; Sergi JA; Dey M; Toner T; Kilgore B; Lay-Fortenbery A; Wang Y; Bian S; Kochert BA; Bothe JR; Gao X; Richardson D; Schuessler HA
    Pharm Res; 2023 Jun; 40(6):1411-1423. PubMed ID: 36627449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction.
    Bickel F; Griaud F; Kern W; Kroener F; Gritsch M; Dayer J; Barteau S; Denefeld B; Kao-Scharf CY; Lang M; Slupska-Muanza I; Schmidt C; Berg M; Sigg J; Boado L; Chelius D
    MAbs; 2023; 15(1):2151075. PubMed ID: 36519228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
    Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A
    J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.
    Kuang J; Tao Y; Song Y; Chemmalil L; Mussa N; Ding J; Li ZJ
    Anal Bioanal Chem; 2021 Mar; 413(8):2113-2123. PubMed ID: 33543314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit.
    Zhou K; Cao X; Bautista J; Chen Z; Hershey N; Ludwig R; Tao L; Zeng M; Das TK
    J Pharm Sci; 2020 Jan; 109(1):422-428. PubMed ID: 31469998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.
    Sreedhara A; Cordoba A; Zhu Q; Kwong J; Liu J
    Pharm Res; 2012 Jan; 29(1):187-97. PubMed ID: 21809161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS Approach to Decipher a Light Chain Chromatographic Peak Splitting of a Monoclonal Antibody.
    Liu Y; VanAernum Z; Zhang Y; Gao X; Vlad M; Feng B; Cross R; Kilgore B; Newman A; Wang D; Schuessler HA; Richardson DD; Chadwick JS
    Pharm Res; 2023 Dec; 40(12):3087-3098. PubMed ID: 37936013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures.
    Chu GC; Chelius D; Xiao G; Khor HK; Coulibaly S; Bondarenko PV
    Pharm Res; 2007 Jun; 24(6):1145-56. PubMed ID: 17385019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
    Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
    Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unequivocal Identification of Aspartic Acid and
    Hui JO; Flick T; Loo JA; Campuzano IDG
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):1901-1909. PubMed ID: 33390012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of succinimide stability during trypsin digestion for LC-MS analysis.
    Nowak C; Ponniah G; Neill A; Liu H
    Anal Biochem; 2017 Jun; 526():1-8. PubMed ID: 28274724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping.
    Cao M; Xu W; Niu B; Kabundi I; Luo H; Prophet M; Chen W; Liu D; Saveliev SV; Urh M; Wang J
    J Pharm Sci; 2019 Nov; 108(11):3540-3549. PubMed ID: 31374319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
    Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
    Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity.
    Yi M; Sun J; Sun H; Wang Y; Hou S; Jiang B; Xie Y; Ji R; Xue L; Ding X; Song X; Xu A; Huang C; Quan Q; Song J
    MAbs; 2023; 15(1):2215364. PubMed ID: 37229604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody.
    Dick LW; Qiu D; Cheng KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3841-9. PubMed ID: 19819766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule.
    Ouellette D; Chumsae C; Clabbers A; Radziejewski C; Correia I
    MAbs; 2013; 5(3):432-44. PubMed ID: 23608772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
    Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18O labeling method for identification and quantification of succinimide in proteins.
    Xiao G; Bondarenko PV; Jacob J; Chu GC; Chelius D
    Anal Chem; 2007 Apr; 79(7):2714-21. PubMed ID: 17313184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
    Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
    Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.